Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MPP7 is a membrane-associated guanylate kinase (MAGUK) scaffold protein in the p55 Stardust subfamily, crucial for the establishment and maintenance of epithelial cell polarity and tight junctions[1][2]. It functions as an adaptor, forming complexes with other polarity proteins such as DLG1 (discs large homolog 1), and indirectly linking to Crb3 via PALS1 (MPP5). Loss of MPP7 disrupts tight junction assembly and epithelial integrity but does not directly result in disease; rather, polymorphisms in the gene are associated with conditions such as epilepsy and autism spectrum disorder[2]. MPP7 is not a classic therapeutic target, enzyme, receptor, or transporter; it lacks known direct interactions with drugs and is primarily implicated in basic cellular organization rather than direct modulation by pharmaceuticals[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 7 (MPP7).